Five Competitors Confirmed On Canadian Adalimumab

Amgen, Fresenius, Merck And Viatris Confirm Further Launches Of Humira Biosimilars

 
• By Dave Wallace

Multiple competitors have now confirmed the launch of Canadian biosimilar versions of the world’s biggest-selling drug, Humira.

Canada Boxing Gloves Boxer Fight
Multiple biosimilars to adalimumab are duking it out in Canada • Source: Shutterstock

More from Biosimilars

More from Products